Rock Springs Capital Management LP purchased a new stake in Tenet Healthcare Co. (NYSE:THC – Free Report) during the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 129,200 shares of the company’s stock, valued at approximately $16,309,000. Rock Springs Capital Management LP owned about 0.14% of Tenet Healthcare as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in THC. GeoWealth Management LLC grew its holdings in shares of Tenet Healthcare by 39.8% during the 4th quarter. GeoWealth Management LLC now owns 295 shares of the company’s stock worth $37,000 after purchasing an additional 84 shares during the period. WR Wealth Planners LLC grew its stake in Tenet Healthcare by 2,836.4% during the fourth quarter. WR Wealth Planners LLC now owns 323 shares of the company’s stock worth $41,000 after buying an additional 312 shares during the period. Smartleaf Asset Management LLC increased its position in shares of Tenet Healthcare by 30.5% in the fourth quarter. Smartleaf Asset Management LLC now owns 471 shares of the company’s stock worth $59,000 after acquiring an additional 110 shares in the last quarter. Kestra Investment Management LLC acquired a new position in shares of Tenet Healthcare during the 4th quarter valued at $60,000. Finally, Wilmington Savings Fund Society FSB increased its holdings in Tenet Healthcare by 1,352.8% in the 4th quarter. Wilmington Savings Fund Society FSB now owns 523 shares of the company’s stock valued at $66,000 after purchasing an additional 487 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
THC has been the topic of several analyst reports. StockNews.com upgraded Tenet Healthcare from a “hold” rating to a “buy” rating in a report on Thursday, March 13th. Truist Financial lowered their price target on shares of Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating for the company in a report on Monday, January 6th. KeyCorp decreased their price objective on shares of Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Guggenheim began coverage on Tenet Healthcare in a research note on Wednesday, April 9th. They issued a “buy” rating and a $165.00 price target on the stock. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $177.00 target price on shares of Tenet Healthcare in a research note on Thursday, February 13th. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $165.44.
Tenet Healthcare Trading Up 0.9 %
Shares of THC stock opened at $121.47 on Monday. The firm has a market capitalization of $11.46 billion, a PE ratio of 3.77, a price-to-earnings-growth ratio of 1.02 and a beta of 1.77. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.70 and a current ratio of 1.78. Tenet Healthcare Co. has a 1 year low of $90.03 and a 1 year high of $171.20. The stock has a fifty day moving average of $127.88 and a two-hundred day moving average of $138.01.
Tenet Healthcare (NYSE:THC – Get Free Report) last released its earnings results on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. As a group, research analysts expect that Tenet Healthcare Co. will post 12.24 EPS for the current year.
Insider Activity
In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of Tenet Healthcare stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the transaction, the director now owns 27,378 shares in the company, valued at approximately $3,434,022.54. The trade was a 25.81 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.93% of the company’s stock.
Tenet Healthcare Company Profile
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Featured Stories
- Five stocks we like better than Tenet Healthcare
- How to Use the MarketBeat Excel Dividend Calculator
- With a 60%+ Upside, There’s Plenty to Love About Lovesac
- Find and Profitably Trade Stocks at 52-Week Lows
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- What Investors Need to Know to Beat the Market
- AppLovin: Can Record Profits Overcome Market Skepticism?
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.